These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 18172860

  • 1. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 2. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 3. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1118-26. PubMed ID: 8757191
    [Abstract] [Full Text] [Related]

  • 4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May 21; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ.
    J Natl Cancer Inst; 2008 Feb 06; 100(3):170-83. PubMed ID: 18230794
    [Abstract] [Full Text] [Related]

  • 9. Androgens and prostate cancer risk: a prospective study.
    Wirén S, Stocks T, Rinaldi S, Hallmans G, Bergh A, Stenman UH, Kaaks R, Stattin P.
    Prostate; 2007 Aug 01; 67(11):1230-7. PubMed ID: 17562541
    [Abstract] [Full Text] [Related]

  • 10. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.
    Am J Epidemiol; 2008 Dec 15; 168(12):1416-24. PubMed ID: 18945688
    [Abstract] [Full Text] [Related]

  • 11. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M.
    Int J Cancer; 2004 Jan 20; 108(3):418-24. PubMed ID: 14648709
    [Abstract] [Full Text] [Related]

  • 12. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
    García-Cruz E, Carrión Puig A, García-Larrosa A, Sallent A, Castañeda-Argáiz R, Piqueras M, Ribal MJ, Leibar-Tamayo A, Romero-Otero J, Alcaraz A.
    Scand J Urol; 2013 Aug 20; 47(4):282-9. PubMed ID: 23181478
    [Abstract] [Full Text] [Related]

  • 13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, Brinton LA.
    Cancer Causes Control; 2004 Feb 04; 15(1):45-53. PubMed ID: 14970734
    [Abstract] [Full Text] [Related]

  • 15. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study.
    Hyde Z, Flicker L, McCaul KA, Almeida OP, Hankey GJ, Chubb SA, Yeap BB.
    Cancer Epidemiol Biomarkers Prev; 2012 Aug 04; 21(8):1319-29. PubMed ID: 22828207
    [Abstract] [Full Text] [Related]

  • 16. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S, Egevad L, Gann PH, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Sieri S, Vineis P, Palli D, Quirós JR, Ardanaz E, Chirlaque MD, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Bikou C, Trichopoulos D, Stattin P, Jenab M, Ferrari P, Slimani N, Riboli E, Kaaks R.
    Int J Cancer; 2007 Sep 15; 121(6):1331-8. PubMed ID: 17514649
    [Abstract] [Full Text] [Related]

  • 17. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
    Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM.
    Cancer Causes Control; 2016 Feb 15; 27(2):175-82. PubMed ID: 26589415
    [Abstract] [Full Text] [Related]

  • 18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 19. Variant in sex hormone-binding globulin gene and the risk of prostate cancer.
    Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, Crawford ED, Hayes RB.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 20; 16(1):165-8. PubMed ID: 17220347
    [Abstract] [Full Text] [Related]

  • 20. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES.
    Anic GM, Albanes D, Rohrmann S, Kanarek N, Nelson WG, Bradwin G, Rifai N, McGlynn KA, Platz EA, Mondul AM.
    Clin Endocrinol (Oxf); 2016 Aug 20; 85(2):258-66. PubMed ID: 26991691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.